About: Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2011 (uk) article scientifique (publié 2011) (fr) im Januar 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2011 (ast) artikull shkencor i botuar më 01 janar 2011 (sq) scientific article published on 01 January 2011 (en)
publication date	wds:Q57205302-466F2B3A-70B3-496C-B0A4-13844D13C2A2
publication date	2011-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q57205302-267037BA-FF9B-47F3-BC9F-63F31090F6A2 wds:Q57205302-5813B147-03CF-4ADC-B277-483D887CE051 wds:Q57205302-5A80F6FD-E866-430B-9219-5D0F3E368D78 wds:Q57205302-607113CB-9F61-4D44-9C0D-45EA82D0C2C8 wds:Q57205302-9B8AEFDC-80CD-4376-B0F1-DB74A45E6C8A wds:Q57205302-A214D919-38D5-417A-B74D-AA7683AE3CC0 wds:Q57205302-A7723095-CFE5-4112-95F7-9FE4FC2A3463 wds:Q57205302-A9ADDCC0-9496-4890-976C-007B108DF3D5 wds:Q57205302-D47AAF2B-20E7-41CF-BAFE-05C79866B80A wds:Q57205302-F7D29505-FA57-4DE7-8643-ABB409F65B89
author name string	Chun-Jen Liu Pei-Jer Chen Ching-Sheng Hsu Ding-Shinn Chen Sheng-Shun Yang Ming-Lung Yu Chen-Hua Liu Chih-Lin Lin Stephanie Fang-Tzu Kuo Corinna Jen-Hui Pan
rdfs:label	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (en) Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (nl) Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (sq)
skos:prefLabel	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (en) Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (nl) Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (sq)
name	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (en) Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (nl) Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (sq)
author	wds:Q57205302-0F343CE5-4777-436B-9804-79699D81E686 wds:Q57205302-A49295F8-DB5D-4327-818B-7BF3654F1CA3 wds:Q57205302-B1AB2B61-ECCA-4EF7-8EAE-E37FB36C3909 wds:Q57205302-B2301E9B-45A7-466C-B5B0-26C5607EF59B
author	Jia-Horng Kao Chien-Wei Su Tai-Chung Tseng Yi-Wen Huang
title	wds:Q57205302-DB6E54AF-4A3B-4A92-BD68-89BAC08FAD81
title	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy (en)
page(s)	wds:Q57205302-447CF580-90ED-450B-ABB2-FB0BA4DC668B
page(s)	629-637
instance of	wds:Q57205302-E0188FBC-F4A5-45BA-98FB-74FA07B73690
instance of	scholarly article
main subject	wds:Q57205302-4406F908-37B3-4F96-91BC-36E8F286D155 wds:Q57205302-733FF1D0-3267-4BCC-B24C-5E7E9B8BD099
main subject	chronic hepatitis B chronic hepatitis
PubMed ID	wds:Q57205302-7B420BDB-9B4B-4B24-BA2F-F0FE3A33D0FD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21817184
PubMed ID	21817184
published in	wds:Q57205302-D00A0615-C23C-436D-A034-CAB72EA0EFB7
published in	Antiviral Therapy
issue	wds:Q57205302-09C242BE-7B22-464B-AAA0-562FB10A906D
volume	wds:Q57205302-1CE6E9D8-293D-4D01-9B4F-A66F54823F96
issue	5
volume	16
DOI	wds:Q57205302-62F0918E-C50E-4FF2-BACE-CBE3794F065B
DOI	http://dx.doi.org/10.3851/IMP1841
DOI	10.3851/IMP1841
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57205302
is cites work of	Update on hepatitis B virus infection Chronic hepatitis B: Advances in treatment Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Clinical Relevance of HLA Gene Variants in HBV Infection Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission Theoretical basis of a beneficial role for vitamin D in viral hepatitis Hepatitis B virus genotypes and variants. The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infection. Interleukin 28B genetic polymorphism and hepatitis B virus infection Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B. Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Review article: genetic factors that modify the outcome of viral hepatitis IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α. Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B. Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients. Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection Polymorphisms of CYP27B1 are associated with IFN efficacy in HBeAg-positive patients. Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON). Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? Virus and Host Testing to Manage Chronic Hepatitis B. One more piece in the interleukin 28B gene puzzle? The case of hepatitis B. Peginterferon α in the treatment of chronic hepatitis B.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software